• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CTS Corporation Announces Appointment of Amy M. Dodrill to its Board of Directors

    2/8/24 5:30:00 PM ET
    $CTS
    $PRCT
    Electrical Products
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $CTS alert in real time by email

    LISLE, Ill., Feb. 08, 2024 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced that Amy M. Dodrill has been appointed to its board of directors, effective February 8, 2024, and will serve as a member of the nominating, governance and sustainability and technology and transactions committees.

    Ms. Dodrill comes to CTS with over 25 years of experience in medical and technology companies and a proven track record of successfully leading and profitably growing global businesses serving key end markets. Ms. Dodrill most recently served as President of Baxter's Global Surgical Solutions and Patient Support Systems segment, a $2 billion business with innovative products focused on advancing connected care and patient outcomes. In that role, Ms. Dodrill successfully integrated two former Hillrom business units into Baxter. Ms. Dodrill is a member of the board of directors of Procept BioRobotics (NASDAQ:PRCT), a commercial stage surgical robotics company, serving on the audit and compensation committees.

    "CTS is pleased to welcome Amy Dodrill to the CTS board.   Her extensive experience in the medical end market and background leading global businesses make her a valuable addition to our already highly experienced and diverse group of directors as CTS continues to focus on growth, end-market diversification, and products that sense, connect and move," said Kieran O'Sullivan, Chairman, President and CEO of CTS.

    About CTS

    CTS (NYSE:CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com.

    Contact

    Ashish Agrawal

    Vice President and Chief Financial Officer

    CTS Corporation

    4925 Indiana Avenue

    Lisle, IL 60532

    USA

    Telephone: +1 (630) 577-8800

    Email: ashish.agrawal@ctscorp.com



    Primary Logo

    Get the next $CTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTS
    $PRCT

    CompanyDatePrice TargetRatingAnalyst
    PROCEPT BioRobotics Corporation
    $PRCT
    12/12/2025$62.00Buy
    UBS
    PROCEPT BioRobotics Corporation
    $PRCT
    12/8/2025$38.00Buy → Neutral
    BofA Securities
    PROCEPT BioRobotics Corporation
    $PRCT
    9/2/2025$60.00Perform → Outperform
    Oppenheimer
    PROCEPT BioRobotics Corporation
    $PRCT
    7/9/2025$70.00Overweight
    Stephens
    PROCEPT BioRobotics Corporation
    $PRCT
    7/7/2025Perform
    Oppenheimer
    PROCEPT BioRobotics Corporation
    $PRCT
    12/2/2024$105.00Overweight
    Morgan Stanley
    PROCEPT BioRobotics Corporation
    $PRCT
    11/14/2024$95.00Hold
    Jefferies
    CTS Corporation
    $CTS
    2/7/2024$46.00Buy → Neutral
    Sidoti
    More analyst ratings

    $CTS
    $PRCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO O'Sullivan Kieran M covered exercise/tax liability with 3,680 shares, decreasing direct ownership by 0.89% to 410,730 units (SEC Form 4)

    4 - CTS CORP (0000026058) (Issuer)

    2/9/26 4:06:49 PM ET
    $CTS
    Electrical Products
    Technology

    CFO Agrawal Ashish covered exercise/tax liability with 931 shares, decreasing direct ownership by 0.88% to 105,056 units (SEC Form 4)

    4 - CTS CORP (0000026058) (Issuer)

    2/9/26 4:04:48 PM ET
    $CTS
    Electrical Products
    Technology

    Senior Vice President Trivedi Pratik covered exercise/tax liability with 289 shares, decreasing direct ownership by 3% to 8,063 units (SEC Form 4)

    4 - CTS CORP (0000026058) (Issuer)

    2/9/26 4:02:36 PM ET
    $CTS
    Electrical Products
    Technology

    $CTS
    $PRCT
    SEC Filings

    View All

    CTS Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CTS CORP (0000026058) (Filer)

    2/10/26 8:01:28 AM ET
    $CTS
    Electrical Products
    Technology

    CTS Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CTS CORP (0000026058) (Filer)

    2/10/26 8:00:28 AM ET
    $CTS
    Electrical Products
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by PROCEPT BioRobotics Corporation

    SCHEDULE 13G/A - PROCEPT BioRobotics Corp (0001588978) (Subject)

    1/8/26 9:09:46 AM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    $CTS
    $PRCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS initiated coverage on PROCEPT BioRobotics with a new price target

    UBS initiated coverage of PROCEPT BioRobotics with a rating of Buy and set a new price target of $62.00

    12/12/25 8:54:55 AM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    PROCEPT BioRobotics downgraded by BofA Securities with a new price target

    BofA Securities downgraded PROCEPT BioRobotics from Buy to Neutral and set a new price target of $38.00

    12/8/25 8:31:34 AM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    PROCEPT BioRobotics upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded PROCEPT BioRobotics from Perform to Outperform and set a new price target of $60.00

    9/2/25 8:22:53 AM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    $CTS
    $PRCT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Moll Frederic H bought $785,138 worth of shares (20,000 units at $39.26), increasing direct ownership by 2% to 863,159 units (SEC Form 4)

    4 - PROCEPT BioRobotics Corp (0001588978) (Issuer)

    8/14/25 4:18:26 PM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    $CTS
    $PRCT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CTS Announces Fourth Quarter and Full Year 2025 Results

    LISLE, Ill., Feb. 10, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of highly engineered solutions that "Sense, Connect and Move," today announced fourth quarter and full year 2025 results. "CTS delivered another quarter of strong performance, with diversified end‑market sales up 16% year over year, and closed 2025 with solid results. Diversified end-markets now represent 57% of revenue, demonstrating progress on our strategic priorities" said Kieran O'Sullivan, CEO of CTS Corporation. "Our teams executed well, driving profitable growth, margin expansion, and strong cash generation. We expanded our product offering in the transportation ma

    2/10/26 8:00:00 AM ET
    $CTS
    Electrical Products
    Technology

    PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference

    SAN JOSE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (NASDAQ:PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of management will present at two upcoming investor conferences in March. TD Cowen 46th Annual Health Care Conference Location – Boston, MAFireside Chat – Monday, March 2nd at 11:40am ET 2026 Leerink Global Health Care Conference Location – Miami, FLFireside Chat – Tuesday, March 10th at 8am ET A live webcast of each event, as well as an archived recording, will be available on the "Investors" section of the Company's website at: https://ir.pr

    2/4/26 4:03:00 PM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    CTS Corporation Announces Date for Fourth Quarter and Full-Year 2025 Earnings Release and Conference Call

    LISLE, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) will release its earnings for the fourth quarter and full-year 2025 at approximately 8:00 a.m. (ET) on Tuesday, February 10, 2026. A conference call to discuss fourth quarter and full-year 2025 results with management is scheduled for Tuesday, February 10, 2026 at 10:00 a.m. (ET). The conference call can be accessed by registering online at CTS Corporation Q4 2025 Earnings Call, at which time registrants will receive dial-in information as well as a conference ID. A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation a

    1/28/26 12:25:25 PM ET
    $CTS
    Electrical Products
    Technology

    $CTS
    $PRCT
    Financials

    Live finance-specific insights

    View All

    CTS Announces Fourth Quarter and Full Year 2025 Results

    LISLE, Ill., Feb. 10, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of highly engineered solutions that "Sense, Connect and Move," today announced fourth quarter and full year 2025 results. "CTS delivered another quarter of strong performance, with diversified end‑market sales up 16% year over year, and closed 2025 with solid results. Diversified end-markets now represent 57% of revenue, demonstrating progress on our strategic priorities" said Kieran O'Sullivan, CEO of CTS Corporation. "Our teams executed well, driving profitable growth, margin expansion, and strong cash generation. We expanded our product offering in the transportation ma

    2/10/26 8:00:00 AM ET
    $CTS
    Electrical Products
    Technology

    CTS Corporation Announces Date for Fourth Quarter and Full-Year 2025 Earnings Release and Conference Call

    LISLE, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) will release its earnings for the fourth quarter and full-year 2025 at approximately 8:00 a.m. (ET) on Tuesday, February 10, 2026. A conference call to discuss fourth quarter and full-year 2025 results with management is scheduled for Tuesday, February 10, 2026 at 10:00 a.m. (ET). The conference call can be accessed by registering online at CTS Corporation Q4 2025 Earnings Call, at which time registrants will receive dial-in information as well as a conference ID. A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation a

    1/28/26 12:25:25 PM ET
    $CTS
    Electrical Products
    Technology

    PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City

    SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ:PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter of 2025 after market close on Tuesday, February 24, 2026. The Company's management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. The Company also announced it will host an in-person investor day event on Wednesday, February 25, 2026, at the NASDAQ Headquarters in New York City beginning at 8:00am Eastern Time. Guests are encouraged to register in advance by clic

    1/26/26 4:03:00 PM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    $CTS
    $PRCT
    Leadership Updates

    Live Leadership Updates

    View All

    CTS Corporation Appoints Pratik Trivedi as Chief Operating Officer

    LISLE, Ill. , Nov. 26, 2025 (GLOBE NEWSWIRE) -- CTS Corporation today announced the appointment of Pratik Trivedi to Chief Operating Officer (COO), effective December 5. Mr. Trivedi, who is Senior Vice President at CTS, brings deep industry experience from prior leadership positions at Eaton Corporation and Cummins Inc. "I am very pleased that Pratik will assume the role of COO. His experience, focus and leadership will be important to executing our growth strategy," commented Kieran O'Sullivan, Chairman and CEO of CTS.  "Pratik has demonstrated an ability to lead and deliver results since joining CTS and I am confident that he will be highly effective as COO."   About CTS CTS Corporat

    11/26/25 9:15:00 AM ET
    $CTS
    Electrical Products
    Technology

    CTS Corporation Announces Appointment of Kimberly Banks MacKay to its Board of Directors

    LISLE, Ill., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS), a leading global designer and manufacturer of custom engineered solutions that "Sense, Connect and Move," today announced that Kimberly Banks MacKay has been appointed to its Board of Directors, effective November 5, 2025, and that she will serve as a member of the Nominating, Governance and Sustainability Committee, as well as the Technology and Transactions Committee. Ms. MacKay comes to CTS with over 30 years of experience driving results in multi-national companies serving key end markets. Ms. MacKay currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. Ms. MacKa

    11/6/25 9:00:00 AM ET
    $CTS
    Electrical Products
    Technology

    CTS Corporation Announces the Appointment of Mark Pacioni as Chief Legal & Administrative Officer and Corporate Secretary

    LISLE, Ill., July 01, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE:CTS) today announced that Mark Pacioni has been appointed Chief Legal & Administrative Officer and Corporate Secretary, effective July 1, 2025. Prior to joining CTS, Mr. Pacioni served as Chief Legal Officer and Secretary of CareerBuilder, LLC from 2019 to 2024 and its successor company, CareerBuilder + Monster, from 2024 until June 2025. Prior thereto, he held senior legal roles at The Boeing Co., Molex, Inc., and Knowles Corp. In addition to his in-house experience, Mr. Pacioni was in private practice representing public companies on transactions and governance matters and was Special Counsel at the U.S. Securities and

    7/1/25 9:00:00 AM ET
    $CTS
    Electrical Products
    Technology

    $CTS
    $PRCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PROCEPT BioRobotics Corporation

    SC 13G/A - PROCEPT BioRobotics Corp (0001588978) (Subject)

    11/14/24 1:28:32 PM ET
    $PRCT
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by CTS Corporation

    SC 13G/A - CTS CORP (0000026058) (Subject)

    11/14/24 1:28:29 PM ET
    $CTS
    Electrical Products
    Technology

    SEC Form SC 13G filed by CTS Corporation

    SC 13G - CTS CORP (0000026058) (Subject)

    11/14/24 12:28:26 PM ET
    $CTS
    Electrical Products
    Technology